Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (1y) (2015 - 2026)
Soleno Therapeutics (SLNO) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 65.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.60% |
| Dec 31, 2025 | -2,045.68% |
| Sep 30, 2025 | -2,363.44% |
| Jun 30, 2025 | 93.45% |
| Mar 31, 2025 | 119.90% |
| Dec 31, 2022 | 53.85% |
| Dec 31, 2021 | -225.00% |
| Dec 31, 2020 | -103.88% |
| Dec 31, 2019 | 159.20% |
| Sep 30, 2019 | 8,920.00% |
| Dec 31, 2018 | -1,260.00% |
| Sep 30, 2018 | -103.50% |
| Dec 31, 2017 | 189.93% |
| Sep 30, 2017 | 7,250.00% |
| Mar 31, 2017 | 78.95% |
| Dec 31, 2016 | 47.51% |
| Sep 30, 2016 | 99.84% |
| Jun 30, 2016 | 96.67% |
| Mar 31, 2016 | -1,800.00% |
| Jun 30, 2015 | -900.00% |